Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A

References

• Guo R, Mao YP, Tang LL, Chen L, Sun Y, Ma J. The evolution of nasopharyngeal carcinoma staging. Br J Radiol. 2019;92(1102):20190244. doi:10.1259/bjr.20190244
   PubMed Web of Science ®Google Scholar
• Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90. doi:10.1186/s40880-017-0257-9
   PubMedGoogle Scholar
• Bao L, You B, Shi S, et al. Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10. Oncogene. 2018;37(21):2873–2889. doi:10.1038/s41388-018-0183-6
   PubMed Web of Science ®Google Scholar
• Lin C, Zong J, Lin W, et al. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-kappaB and Erk1/2 pathways. J Exp Clin Cancer Res. 2018;37(1):283. doi:10.1186/s13046-018-0953-6
   PubMed Web of Science ®Google Scholar
• Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15(10):1765–1777. doi:10.1158/1055-9965.EPI-06-0353
   PubMed Web of Science ®Google Scholar
• Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007;9(12):1–24. doi:10.1017/S1462399407000312
   PubMedGoogle Scholar
• Cai L, Long Y, Chong T, et al. EBV-miR-BART7-3p imposes stemness in Nasopharyngeal Carcinoma cells by suppressing SMAD7. Front Genet. 2019;10:939. doi:10.3389/fgene.2019.00939
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhang N, Zhao S, Chen X, Li F, Tao X. miR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting Axin2 in liver cancer. Oncol Lett. 2019;18(6):6491–6500. doi:10.3892/ol.2019.11056
   PubMed Web of Science ®Google Scholar
• Kang J, Huang X, Dong W, Zhu X, Li M, Cui N. MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3). Bioengineered. 2021;12(1):1150–1160. doi:10.1080/21655979.2021.1909951
   PubMed Web of Science ®Google Scholar
• Wang L, Ge S, Zhou F. MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A. Bioengineered. 2021;12(1):937–947. doi:10.1080/21655979.2021.1884396
   PubMed Web of Science ®Google Scholar
• Cao S, Li N, Liao X. miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer. J Ovarian Res. 2021;14(1):23. doi:10.1186/s13048-020-00760-2
   PubMed Web of Science ®Google Scholar
• Yuan J, Li T, Yi K, Hou M. The suppressive role of miR-362-3p in epithelial ovarian cancer. Heliyon. 2020;6(7):e04258. doi:10.1016/j.heliyon.2020.e04258
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang X, Sun Y, et al. MicroRNA-362-3p inhibits migration and invasion via targeting BCAP31 in cervical cancer. Front Mol Biosci. 2020;7:107. doi:10.3389/fmolb.2020.00107
   PubMed Web of Science ®Google Scholar
• Su Y, Yu QH, Wang XY, et al. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression. BMC Cancer. 2017;17(1):477. doi:10.1186/s12885-017-3473-4
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Wu RS, Qiu EH, Zhu JJ, Wang JR, Lin HL. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(16):8240. doi:10.26355/eurrev_202008_22580
   PubMedGoogle Scholar
• Zhao M, Luo R, Liu Y, et al. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN. Nat Commun. 2016;7:11309. doi:10.1038/ncomms11309
   PubMed Web of Science ®Google Scholar
• Yin W, Shi L, Mao Y. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression. FEBS Open Bio. 2019;9(1):43–52. doi:10.1002/2211-5463.12545
   PubMed Web of Science ®Google Scholar
• Xu G, Fang P, Chen K, Xu Q, Song Z, Ouyang Z. MicroRNA-362-3p targets PAX3 to inhibit the development of glioma through mediating Wnt/beta-Catenin pathway. Neuroimmunomodulation. 2019;26(3):119–128. doi:10.1159/000499766
   PubMed Web of Science ®Google Scholar
• Wang D, Wang H, Li Y, Li Q. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma. Biosci Rep. 2018;38(3):BSR20180668.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhou Z. MicroRNA-432 acts as a prognostic biomarker and an inhibitor of cell proliferation, migration, and invasion in breast cancer. Clin Breast Cancer. 2021;21(4):e462–e470. doi:10.1016/j.clbc.2021.01.014
   PubMed Web of Science ®Google Scholar
• Zhang J, Kong X, Shi Q, Zhao B. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer. Cancer Biomark. 2020;27(4):423–432. doi:10.3233/CBM-190704
   PubMed Web of Science ®Google Scholar
• Ye SB, Zhang H, Cai TT, et al. Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma. J Pathol. 2016;240(3):329–340. doi:10.1002/path.4781
   PubMed Web of Science ®Google Scholar
• Hua X, Fan KC. Down-regulation of miR-1181 indicates a dismal prognosis for nasopharyngeal carcinoma and promoted cell proliferation and metastasis by modulating Wnt/beta-catenin signaling. Eur Rev Med Pharmacol Sci. 2019;23(3):1077–1086. doi:10.26355/eurrev_201902_16996
   PubMed Web of Science ®Google Scholar
• Song L, Liu S, Yao H, et al. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma. Biomed Pharmacother/Biomedecine & Pharmacotherapie. 2019;115:108944. doi:10.1016/j.biopha.2019.108944
   PubMed Web of Science ®Google Scholar
• Cui L, Qi Y, Li H, et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One. 2011;6(11):e27071. doi:10.1371/journal.pone.0027071
   PubMed Web of Science ®Google Scholar
• Zou X, Zhong J, Li J, et al. miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells. Mol Med Rep. 2016;13(1):994–1002. doi:10.3892/mmr.2015.4632
   PubMed Web of Science ®Google Scholar
• Assiri AA, Mourad N, Shao M, et al. MicroRNA 362-3p reduces hERG-related current and inhibits breast cancer cells proliferation. Cancer Genomics Proteomics. 2019;16(6):433–442. doi:10.21873/cgp.20147
   PubMed Web of Science ®Google Scholar
• Wang F, Li Y, Shan F, et al. Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG. Oncol Rep. 2019;42(4):1431–1440. doi:10.3892/or.2019.7246
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Y, Xie Z, Hu H. JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR4915p. Mol Med Rep. 2019;19(4):2489–2496. doi:10.3892/mmr.2019.9916
   PubMed Web of Science ®Google Scholar